Japan Again Questions Tamiflu’s Possible Psychiatric Effects
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese health officials ask Roche subsidiary Chugai to add warnings about giving the drug to teens.
You may also be interested in...
Tamiflu, Relenza Labels Adjusted To Cite Influenza As Potential Cause Of Neuro Events
Roche says label change for Tamiflu reflects growing evidence there is no causal relationship between the drug and neuropsychiatric events.
Tamiflu, Relenza Labels Adjusted To Cite Influenza As Potential Cause Of Neuro Events
Roche says label change for Tamiflu reflects growing evidence there is no causal relationship between the drug and neuropsychiatric events.
FDA Changes Advisory Committee Voting Procedure To Ensure Integrity Of Vote Results
FDA advisory committee members would vote simultaneously rather than sequentially on issues before the panel to avoid influencing each others' votes, according to draft guidance.